vadimezan has been researched along with indazoles in 1 studies
Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (indazoles) | Trials (indazoles) | Recent Studies (post-2010) (indazoles) |
---|---|---|---|---|---|
272 | 16 | 101 | 5,609 | 550 | 3,265 |
Protein | Taxonomy | vadimezan (IC50) | indazoles (IC50) |
---|---|---|---|
Chain A, Cell Division Protein Kinase 2 | Homo sapiens (human) | 185 | |
Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
Chain A, Cell Division Protein Kinase 2 | Homo sapiens (human) | 185 | |
Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
Chain A, Cell Division Protein Kinase 2 | Homo sapiens (human) | 185 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Döme, B; Magyar, M | 1 |
1 review(s) available for vadimezan and indazoles
Article | Year |
---|---|
[Tumor vasculature as a therapeutic target in non-small cell lung cancer].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Axitinib; Benzenesulfonates; Bevacizumab; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Humans; Imidazoles; Indazoles; Indoles; Lung Neoplasms; Niacinamide; Oligonucleotides; Phenylurea Compounds; Piperidines; Pyridines; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Sorafenib; Sulfonamides; Xanthones | 2008 |